Brown and colleagues1 reported the results of a systematic review of the literature aimed in determining whether greater extent of resection (EOR) is associated with improved 1- and 2-year overall survival and 6-month and 1-year progression-free survival in patients affected by glioblastoma multiforme. The analysis revealed 37 studies suitable for inclusion. The authors found that gross total resection (GTR) for glioblastoma multiforme reduces 1- and 2-year mortality, thus supporting GTR over subtotal resection and biopsy.
Grasso, G. (2016). Extent of resection and survival in glioblastoma multiforme. JAMA ONCOLOGY, 2(11), 1508-1509 [10.1001/jamaoncol.2016.3806].
Extent of resection and survival in glioblastoma multiforme
Grasso, G.
2016-01-01
Abstract
Brown and colleagues1 reported the results of a systematic review of the literature aimed in determining whether greater extent of resection (EOR) is associated with improved 1- and 2-year overall survival and 6-month and 1-year progression-free survival in patients affected by glioblastoma multiforme. The analysis revealed 37 studies suitable for inclusion. The authors found that gross total resection (GTR) for glioblastoma multiforme reduces 1- and 2-year mortality, thus supporting GTR over subtotal resection and biopsy.
| File | Dimensione | Formato | |
|---|---|---|---|
|
jama oncology.pdf
Solo gestori archvio
Tipologia:
Post-print
Dimensione
69.47 kB
Formato
Adobe PDF
|
69.47 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
